{"id":"intra-arterial-albumin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypervolemia"},{"rate":null,"effect":"Pulmonary edema"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Infection risk"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Albumin is a natural plasma protein that maintains colloid osmotic pressure, preventing fluid extravasation from the intravascular space into tissues. When administered intra-arterially, it directly increases local blood viscosity and oncotic pressure in target organs, improving perfusion and reducing edema. This mechanism is thought to enhance oxygen delivery and metabolic function in ischemic or hypoperfused tissues.","oneSentence":"Intra-arterial albumin administration increases plasma oncotic pressure and improves microcirculation to enhance tissue perfusion and organ function.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:48:39.019Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute organ ischemia or hypoperfusion (indication under investigation in Phase 3)"}]},"trialDetails":[{"nctId":"NCT03028311","phase":"PHASE1","title":"Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-01-09","conditions":"Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer","enrollment":12},{"nctId":"NCT07365475","phase":"PHASE2","title":"Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2026-01-30","conditions":"Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":306},{"nctId":"NCT07294391","phase":"PHASE2","title":"The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2025-12-10","conditions":"Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":60},{"nctId":"NCT03257033","phase":"PHASE3","title":"Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC","status":"RECRUITING","sponsor":"RenovoRx","startDate":"2018-03-12","conditions":"Locally Advanced Pancreatic Cancer","enrollment":190},{"nctId":"NCT05953623","phase":"PHASE1","title":"Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients","status":"COMPLETED","sponsor":"Tianjin Huanhu Hospital","startDate":"2023-08-01","conditions":"Stroke, Acute Ischemic, Albumin, Endovascular Procedures","enrollment":57},{"nctId":"NCT00199862","phase":"NA","title":"Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-02","conditions":"Colorectal Neoplasms, Colorectal Cancer, Colorectal Tumor","enrollment":30},{"nctId":"NCT05647057","phase":"NA","title":"CPB Prime Fluid Strategies to Preserve Mcirocirculatory Perfusion","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-07-10","conditions":"Endothelial Dysfunction, Hemolysis, Fluid Overload","enrollment":48},{"nctId":"NCT06725498","phase":"PHASE2","title":"Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC","status":"RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2024-12-01","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":50},{"nctId":"NCT06172387","phase":"PHASE1","title":"Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for","status":"UNKNOWN","sponsor":"Tianjin Huanhu Hospital","startDate":"2023-11-01","conditions":"Acute Ischemic Stroke","enrollment":46},{"nctId":"NCT06113848","phase":"PHASE3","title":"Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy","status":"UNKNOWN","sponsor":"Tianjin Huanhu Hospital","startDate":"2023-09-07","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT01077895","phase":"PHASE3","title":"The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function","status":"WITHDRAWN","sponsor":"University Hospital, Ghent","startDate":"2010-02","conditions":"Critically Ill, Intra-Abdominal Hypertension, Abdominal Compartment Syndrome","enrollment":""},{"nctId":"NCT03443921","phase":"NA","title":"Divestment for Artery-involved Pancreatic Cancer","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-03","conditions":"Pancreatic Cancer, Locally Advanced Pancreatic Cancer, Neoadjuvant Therapy","enrollment":122},{"nctId":"NCT01887171","phase":"NA","title":"Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus","status":"COMPLETED","sponsor":"Republican Scientific and Practical Center for Organ and Tissue Transplantation","startDate":"2013-07","conditions":"Early Allograft Dysfunction, Ischemic Reperfusion Injury, Liver Transplantation","enrollment":86},{"nctId":"NCT02761356","phase":"","title":"The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver Malignancies","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2010-01","conditions":"Primary Liver Tumor, Metastatic Liver","enrollment":50},{"nctId":"NCT00833807","phase":"PHASE1","title":"Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-02","conditions":"Melanoma, Liver Metastasis","enrollment":30},{"nctId":"NCT01186263","phase":"PHASE2","title":"Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2010-07","conditions":"Colorectal Cancer, Liver Metastases","enrollment":24},{"nctId":"NCT00518284","phase":"PHASE2","title":"Prevention of Restenosis Following Revascularization","status":"TERMINATED","sponsor":"Celgene Corporation","startDate":"2008-01","conditions":"Vascular Disease, Peripheral","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intra-Arterial Albumin","genericName":"Intra-Arterial Albumin","companyName":"Tianjin Huanhu Hospital","companyId":"tianjin-huanhu-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intra-arterial albumin administration increases plasma oncotic pressure and improves microcirculation to enhance tissue perfusion and organ function. Used for Acute organ ischemia or hypoperfusion (indication under investigation in Phase 3).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}